From the two trial networks conducting the AMP Study, this document provides answers to commonly asked questions about the VRC01 antibody, details on the study design and more.
AMP Study FAQ
AVAC’s World AIDS Day 2020 Letter to the World
On World AIDS Day 2020, AVAC hones in on three things that are essential advocacy priorities for the present moment and in 2021.
• Program for choice.
• Pay for the healthcare workforce to achieve health equity.
• Pursue just, equitable access for COVID-19 vaccines, therapeutics and community-led prevention.
Advocate’s Guide To COVID-19 Vaccine Access
The Advocate’s Guide provides plain-language explanations of the necessary components for equitable COVID-19 vaccine access to help inform and support advocates.
Cheat Sheet: COVID-19 Vaccine Pipeline
This three-pager offers advocates an at-a-glance view of the funders, platforms, research phase and considerations for some of the front-runner candidates.
A Collaborative Approach to HIV Prevention Product Introduction
The HIV prevention product pipeline offers exciting potential to curb HIV incidence. But we know from previous products that translating trial efficacy to population impact is challenging without coordinated effort.
Voluntary Medical Male Circumcision for HIV Prevention (VMMC): An introductory factsheet
This introductory 2-page document explains how VMMC works, reviews the scientific evidence behind it, and outlines key advocacy issues for implementing it.
An Activist’s Guide to Influencing and Monitoring KPIF Rollout
Two-page guide for advocates and activists working on the engagement of key population-led groups in the implementation planning of PEPFAR’s Key Population Investment Fund (KPIF). Includes information on the fund, KPIF countries, lead agencies in each country, activist demands and to-do list.
An Advocate’s Guide to the DAIDS Trial Networks Funding Recompetition Process
This factsheet lays out for advocates how funding decisions under discussion at the US Division of AIDS (DAIDS) could impact communities all over the world. Read on to learn how advocates can help shape the current funding discussion and how the DAIDS process works, for future reference.
Fighting HIV Drug Resistance in Uganda
AVAC Fellow Moses Supercharger has this primer on the upward trend of HIV drug resistance in Uganda, with action items for advocates.
HIV Prevention Trial Terms: An advocate’s guide
This lexicon explains some of the terms used to talk about trials designed to test new HIV prevention tools.